Related Experiment Video
Updated: Mar 15, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Timely Interventions can Increase Smoking Cessation Rate in Men with Ischemic Stroke
Min Jeong Lee1,2, Eunjeong Park3, Hyeon Chang Kim4
1Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
Intensive smoking cessation interventions for men after ischemic stroke, combining hospital education and post-discharge support, significantly improved long-term quitting success compared to usual care.
Area of Science:
- Neurology
- Public Health
- Behavioral Science
Background:
- Smoking cessation is crucial for stroke recovery.
- Many patients struggle with quitting post-stroke.
- Intensive interventions show promise for improving cessation rates.
Purpose of the Study:
- To evaluate the effectiveness of timely interventions for smoking cessation in men with acute ischemic stroke.
- To compare a comprehensive strategy with conventional counseling.
- To demonstrate the utility of early and sustained support.
Main Methods:
- A comparative study involving 157 men with acute ischemic stroke.
- Timely Interventions (TI) group received in-hospital education and post-discharge counseling.
- Conventional Counseling (CC) group received standard care.
- Outcomes measured by point and 12-month sustained smoking cessation rates.
Main Results:
- The TI group achieved a significantly higher point smoking success rate (p= .003).
- Multiple logistic regression revealed the TI group was 2.96 times more likely to sustain smoking cessation for 12 months.
- The study included 157 men with a mean age of 58.25 years.
Conclusions:
- Timely, multi-faceted interventions are more effective than conventional counseling for smoking cessation in male stroke patients.
- Combining in-hospital and post-discharge support enhances long-term cessation success.
- This strategy offers a valuable approach to improve patient outcomes after ischemic stroke.
Related Concept Videos
Atherosclerosis III: Management
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Atherosclerosis IV: Nursing Management
Angina IV: Management
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
